{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:17:14Z","timestamp":1791008234282,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ahj.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T22:04:29Z","timestamp":1600121069000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials"],"prefix":"10.1016","volume":"230","author":[{"given":"Asim","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan Kumar","family":"Ochani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safi U.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayakumar","family":"Sreenivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farouk","family":"Mookadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Doukky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Krasuski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7126","key":"10.1016\/j.ahj.2020.09.001_bb0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/bmj.316.7126.201","article-title":"Understanding controlled trials. Why are randomised controlled trials important?","volume":"316","author":"Sibbald","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2020.09.001_bb0010","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1017\/gmh.2015.29","article-title":"How useful are randomized controlled trials in a rapidly changing world?","volume":"3","author":"Perez-Gomez","year":"2016","journal-title":"Glob Ment Health (Camb)"},{"issue":"23","key":"10.1016\/j.ahj.2020.09.001_bb0015","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.117.026229","article-title":"Composite end points in clinical research: a time for reappraisal","volume":"135","author":"Armstrong","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2020.09.001_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.amjmed.2014.01.011","article-title":"Individual and composite study endpoints: separating the wheat from the chaff","volume":"127","author":"Goldberg","year":"2014","journal-title":"Am J Med"},{"issue":"19","key":"10.1016\/j.ahj.2020.09.001_bb0025","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: greater precision with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ahj.2020.09.001_bb0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cardfail.2005.08.350","article-title":"Key issues in end point selection for heart failure trials: composite end points","volume":"11","author":"Neaton","year":"2005","journal-title":"J Card Fail"},{"issue":"4","key":"10.1016\/j.ahj.2020.09.001_bb0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.5811\/westjem.2018.4.38383","article-title":"Understanding the use of composite endpoints in clinical trials","volume":"19","author":"McCoy","year":"2018","journal-title":"West J Emerg Med"},{"issue":"3","key":"10.1016\/j.ahj.2020.09.001_bb0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1213\/ANE.0000000000003653","article-title":"Survival analysis and interpretation of time-to-event data: the tortoise and the hare","volume":"127","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.ahj.2020.09.001_bb0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/10543406.2011.551327","article-title":"Addressing multiplicity issues of a composite endpoint and its components in clinical trials","volume":"21","author":"Hugue","year":"2011","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.ahj.2020.09.001_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2015.03.071","article-title":"Composite outcome measures in a pragmatic clinical trial of chronic heart failure management: a comparative assessment","volume":"185","author":"Chang","year":"2015","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2020.09.001_bb0055","doi-asserted-by":"crossref","first-page":"612","DOI":"10.7326\/0003-4819-149-9-200811040-00004","article-title":"Composite outcomes in cardiovascular research: a survey of randomized trials","volume":"149","author":"Lim","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2020.09.001_bb0060","doi-asserted-by":"crossref","first-page":"c3920","DOI":"10.1136\/bmj.c3920","article-title":"Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review","volume":"341","author":"Cordoba","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ahj.2020.09.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034785","article-title":"Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes","volume":"7","author":"Pogue","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2020.09.001_bb0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000445413","article-title":"Composite scores and other outcome measures in stroke trials","volume":"39","author":"Pistola","year":"2016","journal-title":"Front Neurol Neurosci"},{"key":"10.1016\/j.ahj.2020.09.001_bb0075","doi-asserted-by":"crossref","first-page":"j2262","DOI":"10.1136\/bmj.j2262","article-title":"A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis","volume":"357","author":"Kirkham","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ahj.2020.09.001_bb0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12874-017-0462-x","article-title":"A systematic comparison of recurrent event models for application to composite endpoints","volume":"18","author":"Ozga","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"10.1016\/j.ahj.2020.09.001_bb0085","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.3390\/nu6126005","article-title":"Dietary magnesium intake and metabolic syndrome in the adult population: dose-response meta-analysis and meta-regression","volume":"6","author":"Ju","year":"2014","journal-title":"Nutrients"},{"issue":"7597","key":"10.1016\/j.ahj.2020.09.001_bb0090","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.39136.682083.AE","article-title":"Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials","volume":"334","author":"Ferreira-Gonz\u00e1lez","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2020.09.001_bb0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/bmj.330.7491.594","article-title":"Validity of composite end points in clinical trials","volume":"330","author":"Montori","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2020.09.001_bb0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2016.12.001","article-title":"Criteria for use of composite end points for competing risks-a systematic survey of the literature with recommendations","volume":"82","author":"Manja","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"22","key":"10.1016\/j.ahj.2020.09.001_bb0105","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.jcin.2016.08.047","article-title":"Statistical approaches to composite endpoints","volume":"9","author":"Weintraub","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.ahj.2020.09.001_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bcp.13166","article-title":"Composite endpoints and the distortion of risk-benefit analysis","volume":"83","author":"Warren","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"15","key":"10.1016\/j.ahj.2020.09.001_bb0115","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.113.006588","article-title":"Rethinking composite end points in clinical trials: insights from patients and trialists","volume":"130","author":"Stolker","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ahj.2020.09.001_bb0120","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1213\/ANE.0b013e31821796d3","article-title":"Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research","volume":"112","author":"Mascha","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ahj.2020.09.001_bb0125","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1001\/jama.289.19.2575","article-title":"Clinical trials\u2014multiple treatments, multiple end points, and multiple lessons [editorial]","volume":"289","author":"Lauer","year":"2003","journal-title":"JAMA."},{"key":"10.1016\/j.ahj.2020.09.001_bb0130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/01.CIR.0000023219.51483.66","article-title":"Lessons learned from recent cardiovascular clinical trials: part I","volume":"106","author":"DeMets","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.ahj.2020.09.001_bb0135","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/anae.13590","article-title":"The case of the misleading composite\u2014one outcome is better than two","volume":"71","author":"Choi","year":"2016","journal-title":"Anaesthesia."},{"key":"10.1016\/j.ahj.2020.09.001_bb0140","first-page":"283","article-title":"Composite endpoints in clinical trials","volume":"61","author":"Gonz\u00e1lez","year":"2008","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320302544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320302544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:05:17Z","timestamp":1757570717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870320302544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"alternative-id":["S0002870320302544"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2020.09.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}